ChiLob 7/4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ChiLob 7/4, covering 2014-12-02 to 2014-12-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment [Phase 1]